Shareholders' Equity and Capital Stock - Schedule of outstanding RSUs (Details) - USD ($) $ in Thousands |
3 Months Ended | |
|---|---|---|
Mar. 31, 2025 |
Dec. 31, 2024 |
|
| Shareholders Equity and Capital Stock | ||
| Number of RSUs | 762,578 | 1,069,645 |
| Weighted-Average Remaining contractual life (years) | 1 year 3 months 18 days | |
| Aggregate Fair Value | $ 510,927 | |
| December 07, 2025 | ||
| Shareholders Equity and Capital Stock | ||
| Number of RSUs | 283,437 | |
| Weighted-Average Remaining contractual life (years) | 8 months 12 days | |
| Aggregate Fair Value | $ 189,903 | |
| Vesting Date | Dec. 07, 2025 | |
| December 12, 2026 | ||
| Shareholders Equity and Capital Stock | ||
| Number of RSUs | 479,141 | |
| Weighted-Average Remaining contractual life (years) | 1 year 8 months 12 days | |
| Aggregate Fair Value | $ 321,024 | |
| Vesting Date | Dec. 12, 2026 |
| X | ||||||||||
- Definition Aggregate fair value of nonvested award under share-based payment arrangement. Excludes share and unit options. No definition available.
|
| X | ||||||||||
- Definition Date when the awards are vested under share-based payment arrangement. Excludes share and unit options. No definition available.
|
| X | ||||||||||
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|